These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17037302)

  • 21. [New infectious diseases].
    Heinzl S
    Med Monatsschr Pharm; 1983 Feb; 6(2):46-8. PubMed ID: 6835167
    [No Abstract]   [Full Text] [Related]  

  • 22. Cellular immunity in typhoid fever, Legionnaires' disease, amebiasis: role of transfer factor and Levamisole in typhoid fever.
    Tanphaichitra D
    Dev Biol Stand; 1983; 53():35-40. PubMed ID: 6873476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Suppressive effects of macrolides and their derivatives on quorum sensing systems in Pseudomonas aeruginosa].
    Tateda K; Ishii Y; Yamaguchi K; Horikawa M; Ishikuro M
    Jpn J Antibiot; 2003 Feb; 56(1):80-6. PubMed ID: 12723402
    [No Abstract]   [Full Text] [Related]  

  • 24. Legionnaires' disease.
    Cunha BA; Burillo A; Bouza E
    Lancet; 2016 Jan; 387(10016):376-385. PubMed ID: 26231463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Emerging infectious diseases--Legionella pneumophila infections].
    Saito A
    Nihon Naika Gakkai Zasshi; 1997 Nov; 86(11):2039-45. PubMed ID: 9480307
    [No Abstract]   [Full Text] [Related]  

  • 26. Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.
    Bjarnsholt T; Givskov M
    Philos Trans R Soc Lond B Biol Sci; 2007 Jul; 362(1483):1213-22. PubMed ID: 17360273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa.
    Le Berre R; Nguyen S; Nowak E; Kipnis E; Pierre M; Ader F; Courcol R; Guery BP; Faure K;
    Clin Microbiol Infect; 2008 Apr; 14(4):337-43. PubMed ID: 18190582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model.
    Broquet A; Roquilly A; Jacqueline C; Potel G; Caillon J; Asehnoune K
    Crit Care Med; 2014 Jun; 42(6):e441-50. PubMed ID: 24732238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Legionella maceachernii pneumonia in a patient with HIV infection.
    Dumoff K; McGovern PC; Edelstein PH; Nachamkin I
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):141-5. PubMed ID: 15474325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse alveolar hemorrhage due to Legionella pneumonia.
    Sundar KM; Pearce MJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):158-9. PubMed ID: 15281439
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathogenesis of legionnaires' disease pneumonia.
    Fumarola D
    Am J Clin Pathol; 1981 Jan; 75(1):127. PubMed ID: 7457422
    [No Abstract]   [Full Text] [Related]  

  • 32. Prescription of macrolides in community-acquired pneumonia: science or art?
    Rello J
    Chest; 1998 May; 113(5):1155-8. PubMed ID: 9596285
    [No Abstract]   [Full Text] [Related]  

  • 33. Intensive care aspects of severe Legionella pneumonia.
    Power KJ; Bowen DJ
    Anaesthesia; 1986 Jun; 41(6):620-2. PubMed ID: 3728932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New infectious diseases and their treatment. Important developments in the last decade].
    Stahlmann R
    Med Monatsschr Pharm; 1988 Jan; 11(1):7-10. PubMed ID: 3280956
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhaled lactonase reduces Pseudomonas aeruginosa quorum sensing and mortality in rat pneumonia.
    Hraiech S; Hiblot J; Lafleur J; Lepidi H; Papazian L; Rolain JM; Raoult D; Elias M; Silby MW; Bzdrenga J; Bregeon F; Chabriere E
    PLoS One; 2014; 9(10):e107125. PubMed ID: 25350373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapies for intractable respiratory infection due to Pseudomonas aeruginosa].
    Nasu M
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():51-5. PubMed ID: 15796056
    [No Abstract]   [Full Text] [Related]  

  • 37. Legionnaires' disease: a rational approach to therapy.
    Roig J; Rello J
    J Antimicrob Chemother; 2003 May; 51(5):1119-29. PubMed ID: 12668578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel therapeutic strategies to counter Pseudomonas aeruginosa infections.
    Fothergill JL; Winstanley C; James CE
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):219-35. PubMed ID: 22339195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical aspects and treatment of severe Legionnaires' pneumonia].
    Ermakov EV; Chernov AP; Novikov IuK; Kladiti IuG
    Ter Arkh; 1985; 57(3):118-9. PubMed ID: 4002151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Legionnaires' disease (etiology, epidemiology, morphology and pathogenesis of "legionnaires" disease)].
    Shtern RD; Ageev AK
    Arkh Patol; 1982; 44(11):78-85. PubMed ID: 6760836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.